GP T3 (Trijodthyronin, Cytomel)

$39.00

GP T3 (Trijodthyronin, Cytomel) – Manufacturer: Geneza Pharmaceuticals Pharmaceutical name: Liothyronine Sodium Pack: 50 table

SKU: 10077 Category: Tag:

Description

What is GP T3?

GP T3 is produced by Geneza Pharmaceuticals. Its active ingredient is Liothyronine sodium. Liothyronine sodium is a very popular drug for the treatment of thyroid insufficiency and is very efficient in stabilizing the metabolism. Besides its clinical indications, liothyronine sodium is a popular drug among athletes by using it during contest preparation in order to burn of body excess fat. It works by increasing the rate of cellular activity and more rapidly burning the carbohydrates, proteins and fats. When utilized by athletes during contest preparation it decreases the amount of stored fat without the necessity of following a severe diet to restrict calories. Therefore, liothyronine sodium (Cytomel) helps in producing “quality muscles”, as athletes tend to call it. Most often, liothyronine sodium is used in conjunction with Clenbuterol for producing dramatic results. Some athletes claim that when liothyronine sodium is used in conjunction with steroids the anabolic effect dramatically increases.

Possible side effects with GP T3

Some of the possible side effects depend on the tolerance of each individual to the drug. As already mentioned, liothyronine sodium has to be taken for a pre-determined period of time and in strictly set doses. When taken for a long period of time and at a too high dosage, one may get permanent thyroid deficiency. In such a case, liothyronine sodium will have to be taken for life. Avoid such adverse reactions by strictly following the dosing schedule.

Other possible side effects with liothyronine sodium are the following:

  • Headaches;
  • Physical/metabolic disorders;
  • Heart palpitations followed by heartbeat irregularities;
  • Agitation;
  • Shortness of breath and others.

Indications of use and dosage

GP T3 comes in form of tablets of 25mg. In the initial phase of therapy with liothyronine sodium it is important to start with a lower dose and increase it slowly. Therefore, the dosing schedule should be set as follows: a tablet of 25mg in the first day followed by an increase in the dose by one tablet every three to four days. The maximum dose should not exceed 75mg per day. Such a dosing schedule will help the body adjust to the increased thyroid hormone and will also help the body avoid any sudden “shock”. As already mentioned, it is important to keep the level of drug even throughout the therapy with liothyronine sodium. In order to do so, it is recommended to split the dose throughout the day. As women are more sensitive to liothyronine sodium, the dose should not exceed 50mg per day. Another important aspect in setting the dose of liothyronine sodium is the expected result from the therapy with it, either an ongoing edge in fat loss or a substantial increase in rate of fat loss. For the first purpose the dose should not exceed 25mg while for the second 75mg.